Suppr超能文献

遗传性血管性水肿:血浆激肽及血管通透性增强活性的特征

Hereditary angioneurotic oedema: characterization of plasma kinin and vascular permeability-enhancing activities.

作者信息

Shoemaker L R, Schurman S J, Donaldson V H, Davis A E

机构信息

Division of Nephrology, Children's Hospital Research Foundation, Cincinnati, OH 45229.

出版信息

Clin Exp Immunol. 1994 Jan;95(1):22-8. doi: 10.1111/j.1365-2249.1994.tb06009.x.

Abstract

The mediator(s) responsible for localized enhanced vascular permeability that characterizes an exacerbation of hereditary angioneurotic oedema (HAE) is thought to be a product of either contact or complement system activation. In contrast to normal individuals, plasma from these patients generates both kinin and vascular permeability-enhancing activity following incubation at 37 degrees C. Depletion of C1 inhibitor in both normal and C2-deficient plasma, but not in contact factor-deficient plasmas, resulted in generation of these activities. The kinin activity from incubated HAE plasma was susceptible to kininase inactivation and was blocked by a Bk2 receptor antagonist. Furthermore, this activity was isolated from HAE plasma; amino acid sequence analysis proved it to be bradykinin. Similarly, the vasopermeability-enhancing activity from ethanol-fractionated or boiled HAE plasma, collected during either attack or remission, co-eluted with bradykinin on reverse-phase high performance liquid chromatography (HPLC). These studies conclusively demonstrate that bradykinin is the major kinin and mediator of enhanced vascular permeability generated during incubation of HAE plasma. The role of other bioactive products, such as the C2 kinin, at local sites of oedema formation remains to be further defined.

摘要

遗传性血管性水肿(HAE)发作时具有局部血管通透性增强的特征,其相关介质被认为是接触系统或补体系统激活的产物。与正常人不同,这些患者的血浆在37℃孵育后会产生激肽和血管通透性增强活性。在正常血浆和C2缺陷血浆中消耗C1抑制剂可产生这些活性,但在接触因子缺陷血浆中则不会。孵育后的HAE血浆中的激肽活性易被激肽酶灭活,并被Bk2受体拮抗剂阻断。此外,该活性从HAE血浆中分离出来;氨基酸序列分析证明其为缓激肽。同样,在发作期或缓解期收集的经乙醇分级分离或煮沸的HAE血浆中的血管通透性增强活性,在反相高效液相色谱(HPLC)上与缓激肽共洗脱。这些研究确凿地证明,缓激肽是HAE血浆孵育过程中产生的主要激肽和血管通透性增强的介质。其他生物活性产物,如C2激肽,在水肿形成局部部位的作用仍有待进一步明确。

相似文献

7
The pathophysiology of hereditary angioedema.遗传性血管性水肿的病理生理学
Clin Immunol. 2005 Jan;114(1):3-9. doi: 10.1016/j.clim.2004.05.007.
10
[Biological investigation of kinin-mediated angioedema].
Ann Dermatol Venereol. 2015 Mar;142(3):163-9. doi: 10.1016/j.annder.2015.01.018. Epub 2015 Feb 13.

引用本文的文献

3
The Search for Biomarkers in Hereditary Angioedema.遗传性血管性水肿生物标志物的研究
Front Med (Lausanne). 2017 Nov 22;4:206. doi: 10.3389/fmed.2017.00206. eCollection 2017.
4
The Story of Angioedema: from Quincke to Bradykinin.血管性水肿的故事:从昆克到缓激肽。
Clin Rev Allergy Immunol. 2016 Oct;51(2):121-39. doi: 10.1007/s12016-016-8553-8.
6
"Nuts and Bolts" of Laboratory Evaluation of Angioedema.血管性水肿实验室评估的“基本要点”
Clin Rev Allergy Immunol. 2016 Oct;51(2):140-51. doi: 10.1007/s12016-016-8539-6.
7
Pathophysiology of Hereditary Angioedema.遗传性血管性水肿的病理生理学
Pediatr Allergy Immunol Pulmonol. 2014 Dec 1;27(4):159-163. doi: 10.1089/ped.2014.0425.
10
The pathophysiology of hereditary angioedema.遗传性血管性水肿的病理生理学。
World Allergy Organ J. 2010 Sep;3(9 Suppl):S25-8. doi: 10.1097/WOX.0b013e3181f3f21c.

本文引用的文献

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验